Sanofi in talks to acquire Insmed in $26B+ deal
Published 11 h ago1 sourceEvidence: Reported
Eli Lilly has executed 16 acquisitions and strategic alliances totaling $51.1 billion since January, signaling an aggressive diversification push beyond its GLP-1 franchise (Mounjaro/Zepbound). The scale and pace of dealmaking suggest management is hedging against future competition and patent cliffs, though the strategic fit and financing details remain undisclosed.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 11 h ago1 sourceEvidence: Reported
Published 2 d ago3 sourcesEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 19 h ago2 sourcesEvidence: Unknown
Published 15 h ago2 sourcesEvidence: Reported
Published 8 h ago1 sourceEvidence: Reported
Published 12 h ago3 sourcesEvidence: Reported